Ruggaard & Associates »

Regeneron Pharmaceuticals shares owned by Ruggaard & Associates

Quarter-by-quarter ownership of Regeneron Pharmaceuticals (REGN) shares owned by Ruggaard & Associates from 13F filings

Historical chart of Ruggaard & Associates investment in Regeneron Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Regeneron Pharmaceuticals held by Ruggaard & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Regeneron Pharmaceuticals by Ruggaard & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $339k 352 962.49
2023-12-31 $300k 342 878.29
2023-09-30 $332k 403 822.96

More positions owned by Ruggaard & Associates

J P Morgan Exchange Traded F Ultra Shrt Inc (JPST)
Capital Grp Fixed Incm Etf T Core Plus Incm (CGCP)
Ishares Tr Ibonds 2026 Term (IBHF)
Vanguard Index Fds Mid Cap Etf (VO)
Capital Group Dividend Value Shs Creation Uni (CGDV)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Ishares Tr Ibonds Dec24 Etf (IBDP)
Vaneck Etf Trust Mrngstr Wde Moat (MOAT)
American Centy Etf Tr Us Quality Grow (QGRO)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard Index Fds Mcap Vl Idxvip (VOE)
Dimensional Etf Trust Us Small Cap Etf (DFAS)
Apple (AAPL)
Vanguard Index Fds Small Cp Etf (VB)

View all positions for Ruggaard & Associates

Top funds holding Regeneron Pharmaceuticals

FMR
Vanguard Group
BlackRock
Jpmorgan Chase & Co
Geode Capital Management
Dodge & Cox
Franklin Resources
Loomis, Sayles and
Wellington Management Company
Northern Trust
Legal & General Group
Bank of America Corporation
Amundi
Bank of New York Mellon
American Century Companies

View all funds holding Regeneron Pharmaceuticals